Table 3.
Category | Low rate of side effects | Proven cures for hundreds of years | Effectiveness | Comfort | Positive reputation | Doctors’ good explanations | Accessibility of KM information to the public | Others | P-value |
---|---|---|---|---|---|---|---|---|---|
(Average) | (52.7) | (48.7) | (29.6) | (19.0) | (8.9) | (8.4) | (2.2) | (0.7) | 0.019 |
Gender | |||||||||
Male | 52.8 | 57.4 | 29.9 | 19.0 | 8.1 | 7.7 | 2.1 | 0.4 | |
Female | 52.6 | 40.6 | 29.4 | 19.0 | 9.7 | 9.0 | 2.3 | 1.0 | |
Age (yr) | 0.012 | ||||||||
20–29 | 38.6 | 41.6 | 36.6 | 23.8 | 15.8 | 2.0 | 2.0 | 2.0 | |
30–39 | 49.1 | 42.1 | 30.7 | 19.3 | 10.5 | 10.5 | 4.4 | 0.0 | |
40–49 | 51.0 | 49.7 | 32.2 | 16.8 | 8.4 | 11.9 | 2.1 | 0.0 | |
50–59 | 60.4 | 57.0 | 24.8 | 17.4 | 5.4 | 8.1 | 2.0 | 0.0 | |
60–69 | 63.2 | 49.4 | 24.1 | 19.5 | 5.7 | 8.0 | 0.0 | 2.3 |
The 594 respondents who cited KM trust were surveyed. The questions allowed multiple answers. The values represent percentages of participants